Home LiteratureArticle Details
PMID: 9033255 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Aberrant p27kip1 expression in endocrine and other tumors.

The American journal of pathology ·Vol. 150 ·No. 2 ·1997-02-00 ·Pages 401-7

Lloyd RV, Jin L, Qian X, Kulig E

Abstract

The p27kip1 (p27) gene encodes an inhibitor of cyclin-dependent kinase activity. The expression of p27 protein in normal and neoplastic tissues was investigated by immunoblotting and immunohistochemistry. Immunoblotting studies detected a 27-kd protein band that was decreased in neoplastic pituitary tissues compared with normal pituitary. Immunostaining of 177 tissues showed abundant expression of p27 protein in normal tissues with decreased numbers of immunoreactive cells in adenomas and carcinomas in both endocrine and nonendocrine tissues. p27 expression was inversely related to the proliferation marker Ki-67 antigen detected with monoclonal antibody MIB-1. Parathyroid adenomas and hyperplasias had similar Ki-67 labeling indices; however, hyperplasias had threefold more p27-positive cells than parathyroid adenomas, suggesting that p27 immunostaining may be useful in distinguishing between these two conditions. These results indicate that there is widespread aberrant p27 expression in hyperplastic tissues and in benign and malignant neoplasms compared with normal tissues. Immunohistochemical analysis of p27 along with Ki-67 may be used to assess the biological behavior of various neoplasms, to classify hyperplastic and neoplastic tissues, and to study cell cycle regulation during tumor progression.

MeSH Terms
Cell Cycle Proteins Cyclin-Dependent Kinase Inhibitor p27 Endocrine Gland Neoplasms/metabolism Endocrine Glands/metabolism Enzyme Inhibitors/metabolism Humans Hyperplasia Immunoblotting Immunohistochemistry Microtubule-Associated Proteins/metabolism Neoplasms/metabolism Reference Values Tissue Distribution Tumor Suppressor Proteins
Chemicals
Cell Cycle Proteins Enzyme Inhibitors Microtubule-Associated Proteins Tumor Suppressor Proteins Cyclin-Dependent Kinase Inhibitor p27
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Lloyd R V
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
Jin L
Qian X
Kulig E
References (38)
38 references, click to expand
  1. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.
    Cell. 1996 May 31;85(5):733-44 PMID: 8646781
  2. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).
    Cell. 1996 May 31;85(5):721-32 PMID: 8646780
  3. Transforming growth factor-beta and p27 expression in pituitary cells.
    Endocrinology. 1996 Jul;137(7):3051-60 PMID: 8770931
  4. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.
    J Immunol. 1984 Oct;133(4):1710-5 PMID: 6206131
  5. Prolactin and growth hormone synthesis and thymidine incorporation in dissociated rat pituitary tumor cells.
    Proc Soc Exp Biol Med. 1986 Jan;181(1):18-23 PMID: 3945620
  6. Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10.
    Hum Genet. 1989 Oct;83(3):297-9 PMID: 2571566
  7. Ki-67 detects a nuclear matrix-associated proliferation-related antigen. II. Localization in mitotic cells and association with chromosomes.
    J Cell Sci. 1989 Apr;92 ( Pt 4):531-40 PMID: 2689459
  8. Monoclonal antibody Ki-67: its use in histopathology.
    Histopathology. 1990 Dec;17(6):489-503 PMID: 2076881
  9. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues.
    J Pathol. 1992 Sep;168(1):85-6 PMID: 1453271
  10. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  11. p21 is a universal inhibitor of cyclin kinases.
    Nature. 1993 Dec 16;366(6456):701-4 PMID: 8259214
  12. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
    Genes Dev. 1994 Jan;8(1):9-22 PMID: 8288131
  13. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.
    Cell. 1994 Jul 15;78(1):59-66 PMID: 8033212
  14. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
    Cell. 1994 Jul 15;78(1):67-74 PMID: 8033213
  15. G1 phase progression: cycling on cue.
    Cell. 1994 Nov 18;79(4):551-5 PMID: 7954821
  16. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.
    Cell. 1994 Nov 18;79(4):573-82 PMID: 7954824
  17. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
    Genes Dev. 1994 Dec 15;8(24):2939-52 PMID: 8001816
  18. Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias.
    Cancer Res. 1995 Mar 15;55(6):1206-10 PMID: 7882309
  19. p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.
    Cancer Res. 1995 Mar 15;55(6):1211-4 PMID: 7882310
  20. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts.
    Cancer Res. 1995 Apr 1;55(7):1413-6 PMID: 7882344
  21. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.
    Genes Dev. 1995 Mar 15;9(6):639-49 PMID: 7729683
  22. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
    Genes Dev. 1995 Mar 15;9(6):650-62 PMID: 7729684
  23. Cell-cycle regulators and cancer.
    Trends Genet. 1995 Apr;11(4):136-40 PMID: 7732591
  24. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.
    Mol Cell Biol. 1995 May;15(5):2672-81 PMID: 7739547
  25. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
    Cancer Res. 1995 Jun 1;55(11):2266-9 PMID: 7757974
  26. Inhibitors of mammalian G1 cyclin-dependent kinases.
    Genes Dev. 1995 May 15;9(10):1149-63 PMID: 7758941
  27. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression.
    Cancer Res. 1995 Jul 1;55(13):2713-8 PMID: 7796391
  28. Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector.
    Cancer Res. 1995 Aug 1;55(15):3250-3 PMID: 7614457
  29. Role of the cyclin-dependent kinase inhibitors in the development of cancer.
    Blood. 1995 Aug 1;86(3):841-54 PMID: 7620180
  30. Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation.
    Mol Biol Cell. 1995 Sep;6(9):1197-213 PMID: 8534916
  31. Translational control of p27Kip1 accumulation during the cell cycle.
    Science. 1996 Mar 29;271(5257):1861-4 PMID: 8596954
  32. Tumor suppression and inhibition of aneuploid cell accumulation in human brain tumor cells by ectopic overexpression of the cyclin-dependent kinase inhibitor p27KIP1.
    J Clin Invest. 1996 Apr 15;97(8):1983-8 PMID: 8621784
  33. The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons.
    Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3259-63 PMID: 8622924
  34. p27/Kip1 mutation found in breast cancer.
    Cancer Res. 1996 May 15;56(10):2400-4 PMID: 8625318
  35. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle.
    Science. 1996 May 10;272(5263):877-80 PMID: 8629023
  36. Frequent loss of the P16INK4a gene product in human pituitary tumors.
    Cancer Res. 1996 Jun 1;56(11):2493-6 PMID: 8653683
  37. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.
    Cell. 1996 May 31;85(5):707-20 PMID: 8646779
  38. High frequency of aberrant p16(INK4A) expression in human breast cancer.
    Am J Pathol. 1996 Jul;149(1):15-20 PMID: 8686738
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
1997-02-00
Pages
401-7
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1858274
Subset
IM
Grants
NCI NIH HHS · CA 42951 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]